Possibilities of Fucoidan Utilization in the Development of Pharmaceutical Dosage Forms

Marine Drugs - Switzerland
doi 10.3390/md17080458
Full Text
Abstract

Available in full text

Categories
Drug Discovery
Date
Authors
Publisher

MDPI AG

Related search

Development and Validation of Spectrophotometric Methods for Determination of Ceftazidime in Pharmaceutical Dosage Forms

Acta Pharmaceutica
MedicinePharmacologyPharmaceutical Science
2008English

Determination of Emtricitabine by Derivative Spectrophotometric Method in Pharmaceutical Dosage Forms

Chemical Science Transactions
2013English

The Studies on the Pharmaceutical Development of Dosage Forms With Silver and Gold Nanoparticles for Use in Dentistry and Surgery

Vìsnik farmacìï
2018English

Direct Spectrophotometric Determination of Cefuroxime Axetil in Pure Form and Pharmaceutical Dosage Forms.

JOURNAL OF ADVANCES IN CHEMISTRY
2018English

Differential Pulse Voltammetric Determination of Fulvestrant in Pharmaceutical Dosage Forms and Serum Samples

International Journal of Electrochemistry
2011English

Stability Indicating RP-HPLC Method Development and Validation of Cefepime and Amikacin in Pure and Pharmaceutical Dosage Forms

Brazilian Journal of Pharmaceutical Sciences
ToxicologyPharmaceuticsPharmacology
2018English

Development and Validation of a Stability-Indicating UPLC Method for Rosuvastatin and Its Related Impurities in Pharmaceutical Dosage Forms

Quimica Nova
Chemistry
2011English

Novel Statistically Designed QBD Methodology for Quantitative Analysis of Nisoldipine in Pharmaceutical Dosage Forms

Pharmaceutica Analytica Acta
2016English

Development and Validation of Differential Pulse Polarographic Analysis of Fenofibrate in Pure and Pharmaceutical Dosage Forms Using Dropping Mercury Electrode

International Journal of Pharmacy and Pharmaceutical Sciences
PharmacologyPharmaceutical Science
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy